Top Trends Transforming the NGS-Based RNA-Sequencing Market Landscape in 2025: Strategic Partnerships Driving Ngs-Based Rna Sequencing Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the NGS-Based RNA-Sequencing Industry Market Size Be by 2025?
Recent years have witnessed an exceptional expansion in the market size of NGS-based RNA-sequencing. Projection indicates an increase from $3.41 billion in 2024 to $4.23 billion by the end of 2025, maintaining a compound annual growth rate (CAGR) of 24.2%. Factors like genomic research initiatives, lowered sequencing costs, the progress in drug discovery and development, the rise of personalized medicine and the growing acceptance of NGS are significant contributors to the growth realized during the historic period.

What's the Long-Term Growth Forecast for the NGS-Based RNA-Sequencing Market Size Through 2029?
The market size for NGS-based RNA-sequencing is predicted to experience an exponential surge in the upcoming years, reaching $10.4 billion in 2029, with a compound annual growth rate (CAGR) of 25.2%. Factors contributing to this growth during the predicted period include clinical diagnostics, global partnerships, moral and regulatory structures, agricultural and environmental studies, and green genomics. Key trends for the forecasted period are single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

What Are the Key Growth Drivers Fueling the NGS-Based RNA-Sequencing Market Expansion?
The advancement of precision medicine is fuelling the expansion of the NGS-based RNA sequencing market. With its ability to assist physicians in crafting bespoke treatment plans based on genetic insights about a patient's illness, precision medicine is experiencing a surge, particularly for the treatment of severe diseases such as cancer. Using NGS-based RNA sequencing, the root of the illness can be identified, enabling the prescription of appropriate precision medication. For instance, a Personalized Medicine Coalition (PMC) report in February 2023 noted that personalized medicines accounted for 35% of new NME approvals in 2021, and in 2022, they sustained a steady proportion of at least a quarter of new drug approvals for the eighth consecutive year. This highlights a marked increase from just under 10% ten years prior. With the growing demand for precision medicines, it's anticipated that the requirement for NGS-based RNA sequencing will similarly rise.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Are the Key Trends Driving NGS-Based RNA-Sequencing Market Growth?
The trend of Strategic Partnership plays a major role in the landscape of the NGS-based RNA sequencing market. Firms are forming alliances with businesses that focus on NGS-based RNA sequencing in order to broaden their reach in new markets and mutually benefit from each other's resources. For example, in May 2022, the Biomedical Advanced Research and Development Authority (BARDA), an agency of the U.S. Department of Health and Human Services, formed collaborations with various industry and academic associates. The purpose behind these alliances is to enhance the ability to promptly react to public health crises and create a new diagnostic utility that can detect all known and emerging respiratory RNA viruses through a single test.

How Is the NGS-Based RNA-Sequencing Market Segmented?
The ngs-based rna-sequencing market covered in this report is segmented -

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Which Companies Are Leading the Charge in NGS-Based RNA-Sequencing Market Innovation?
Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Which Regions Are Leading the Global NGS-Based RNA-Sequencing Market in Revenue?
North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.